| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/29/2004 | CA2285052C Improvements in or relating to long-acting antimicrobials |
| 06/29/2004 | CA2280685C A medicament against infertility and for increasing fertility |
| 06/29/2004 | CA2275392C New aqueous medicament preparations for the production of propellent gas-free aerosols |
| 06/29/2004 | CA2263913C Substituted 6,6-hetero-bicyclic derivatives |
| 06/29/2004 | CA2234936C Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine |
| 06/29/2004 | CA2207404C Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase |
| 06/29/2004 | CA2205384C Dihydropyrimidines and uses thereof |
| 06/29/2004 | CA2204451C Method of selecting a salt for making an inclusion complex |
| 06/29/2004 | CA2203836C Use of astaxanthin for retarding and ameliorating central nervous system and eye damage |
| 06/29/2004 | CA2178604C Novel imidazole derivative and process for producing the same |
| 06/29/2004 | CA2171827C Use of thiazolidinediones to prevent or delay onset of niddm |
| 06/29/2004 | CA2161256C Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole |
| 06/29/2004 | CA2146645C Plaster for the transdermal administration of volatile, pharmaceutically active, chemically alkaline ingredients and processes for producing the same |
| 06/29/2004 | CA2131285C Pharmaceutical inhalation compositions |
| 06/29/2004 | CA2131002C Effect of particle-size distribution of cellulose ethers on palatability of compositions |
| 06/29/2004 | CA2112399C Methods and compositions for treating malaria and other diseases |
| 06/29/2004 | CA2105215C Novel oxazolidines |
| 06/29/2004 | CA2031518C Endothelial cell-leukocyte adhesion molecules (elams) and molecules involved in leukocyte adhesion (milas) |
| 06/27/2004 | CA2454050A1 Pharmaceutical formulae for thyroid hormones and procedures for obtaining them |
| 06/24/2004 | WO2004053192A1 Orally administered dosage forms of fused gaba analog prodrugs having reduced toxicity |
| 06/24/2004 | WO2004053169A1 Modulation of interleukin 18 expression |
| 06/24/2004 | WO2004053107A2 Methods for treating diabetes |
| 06/24/2004 | WO2004053097A2 Chemopreventive and therapeutic aspects of polyphenolic compositions and assays |
| 06/24/2004 | WO2004053087A2 Nf-κb inhibitors |
| 06/24/2004 | WO2004053069A2 PROTECTION OF STEM CELLS FROM CYTOTOXIC AGENTS BY MODULATION OF β-CATENIN SIGNALING PATHWAYS |
| 06/24/2004 | WO2004053067A2 Methods for inhibiting cancer and scar formation |
| 06/24/2004 | WO2004052906A1 Anhydrous crystalline azido cytosine hemisulfate derivative |
| 06/24/2004 | WO2004052905A2 Antiviral nucleoside derivatives |
| 06/24/2004 | WO2004052904A2 Novel semisynthetic macrolide antibiotics of the azalide series |
| 06/24/2004 | WO2004052903A1 Novel fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof |
| 06/24/2004 | WO2004052902A1 Novel aromatic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof |
| 06/24/2004 | WO2004052899A2 Process for the production of 2'-branched nucleosides |
| 06/24/2004 | WO2004052894A1 Crystalline fumarate salts of 1-azabicyclo[2.2.2]oct substituted furo[2,3-c]pyridinyl carboxamide and compositions and preparations thereof |
| 06/24/2004 | WO2004052892A1 Anhydrous crystalline form of valacyclovir hydrochloride |
| 06/24/2004 | WO2004052886A1 Indol derivatives and their use as 5-ht ligands |
| 06/24/2004 | WO2004052885A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 06/24/2004 | WO2004052879A1 Thiophenederivatives for the treatment of flavivirus infections |
| 06/24/2004 | WO2004052876A1 Substituted 4-phenyl-[1,3]-dioxanes |
| 06/24/2004 | WO2004052875A1 Tyrostatin and related anticancer drugs |
| 06/24/2004 | WO2004052871A1 Benzomorpholine derivatives |
| 06/24/2004 | WO2004052868A1 Pyrazine-based tubulin inhibitors |
| 06/24/2004 | WO2004052863A1 Anti-inflammatory agent |
| 06/24/2004 | WO2004052859A1 Erythropoietin production accelerator |
| 06/24/2004 | WO2004052850A2 Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof |
| 06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
| 06/24/2004 | WO2004052846A1 Tetrahydro-naphthalene derivatives |
| 06/24/2004 | WO2004052845A1 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists |
| 06/24/2004 | WO2004052844A1 Prodrugs of gaba analogs, compositions and uses thereof |
| 06/24/2004 | WO2004052838A1 Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents |
| 06/24/2004 | WO2004052835A1 Levalbuterol salt |
| 06/24/2004 | WO2004052830A1 Chiral arylketones in the treatement of neutrophil-dependent inflammatory deseases |
| 06/24/2004 | WO2004052782A1 Nanocarbon-dissolving aqueous solution, aqueous solution for purification, and method of purification |
| 06/24/2004 | WO2004052461A1 Combination for the treatment of adhd |
| 06/24/2004 | WO2004052407A1 Ultrasound contrast using halogenated xanthenes |
| 06/24/2004 | WO2004052401A2 Compositions and methods of delivery of pharmacological agents |
| 06/24/2004 | WO2004052400A1 Pharmaceutical formulation and a method of making same |
| 06/24/2004 | WO2004052399A1 Composition for topical anesthesia |
| 06/24/2004 | WO2004052385A1 Composition containing green and yellow vegetables and light-colored vegetables |
| 06/24/2004 | WO2004052383A1 An composition containing triterpenoid saponins extracted from bamboo, and the preparation method and use thereof |
| 06/24/2004 | WO2004052378A1 Skin material for external use and antiprutiric agent for external use and wrinkle-reducing instrument using the same |
| 06/24/2004 | WO2004052377A1 Use of spongosine (2-methoxyadenosein) for the treatment of pain, in particular hyperalgesia |
| 06/24/2004 | WO2004052376A1 Method of reducing toxicity of anticancer agents |
| 06/24/2004 | WO2004052375A1 Novel therapeutical use of agonist ligands specific to lysophosphatidic acid receptor |
| 06/24/2004 | WO2004052374A1 Combination medicament |
| 06/24/2004 | WO2004052373A1 Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k |
| 06/24/2004 | WO2004052371A2 Cyclic quinoline compounds for use in mch receptor related disorders |
| 06/24/2004 | WO2004052370A2 Quinoline compounds for use in mch receptor related disorders |
| 06/24/2004 | WO2004052369A1 Pharmaceutical combinations and methods for the treatment of leukemia |
| 06/24/2004 | WO2004052368A1 Use of certain compounds in treatment of obesity |
| 06/24/2004 | WO2004052367A1 Tablet comprising efletirizine and pseudoephedrine |
| 06/24/2004 | WO2004052365A2 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 06/24/2004 | WO2004052364A1 METHODS FOR SUSTAINING eNOS ACTIVITY |
| 06/24/2004 | WO2004052362A1 Combination of an dpp-iv inhibitor and a ppar-alpha compound |
| 06/24/2004 | WO2004052361A1 Microtubule stabilisers for treating stenosis in stents |
| 06/24/2004 | WO2004052360A1 Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof |
| 06/24/2004 | WO2004052359A1 Methods for selectively inhibiting janus tyrosine kinase 3 (jak3) |
| 06/24/2004 | WO2004052358A1 Urushiol induced contact dermatitis treatment and method of use |
| 06/24/2004 | WO2004052357A1 Labeled macrophage scavenger receptor antagonists for imaging cardiovascular diseases |
| 06/24/2004 | WO2004052356A1 Composition for the treatment of pain, especially for the treatment of articular pain |
| 06/24/2004 | WO2004052355A1 Use of n-chlorotaurine for treatment of oozing tissue deficiencies |
| 06/24/2004 | WO2004052354A1 Propofol-containing fat emulsions |
| 06/24/2004 | WO2004052353A2 Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid |
| 06/24/2004 | WO2004052352A1 Formulation, which can be administered gastrointestinally, containing green tea extract and an no donor |
| 06/24/2004 | WO2004052351A1 Novel use of lycopene |
| 06/24/2004 | WO2004052350A2 Method of treating movement disorders using barbituric acid derivatives |
| 06/24/2004 | WO2004052349A2 Compositions comprising a combination of diphenyl ura impdh inhibitors and apoptosis-inducing anti-cancer agents |
| 06/24/2004 | WO2004052348A2 Treatment of diseases with combinations of alpha 7 nicotinic acetylcholine receptor agonists and other compounds |
| 06/24/2004 | WO2004052346A1 Pharmaceutical compositions containing indistinguishable drug components |
| 06/24/2004 | WO2004052345A1 Coating composition for taste masking coating and methods for their application and use |
| 06/24/2004 | WO2004052343A1 Controlled-release of an active substance into a high fat environment |
| 06/24/2004 | WO2004052342A1 A new oral immediated release dosage form |
| 06/24/2004 | WO2004052333A1 Pharmaceutical compositions for the pulmonary delivery of aztreonam |
| 06/24/2004 | WO2004052326A1 Pharmaceutical or cosmetic composition, preventing or reducing itch and local reaction from stings of insects |
| 06/24/2004 | WO2004052315A2 Tyrosine kinase inhibitors |
| 06/24/2004 | WO2004052313A2 Anti-infectives |
| 06/24/2004 | WO2004052308A2 Topical anti-infective formulations |
| 06/24/2004 | WO2004052299A2 MODIFICATION OF CYCLOOXYGENASE AND LIPOXYGENASE ACTIVITY WITH ASTERIDAE EXTRACTS AND OPTIONALLy BOSWELLIC ACID |
| 06/24/2004 | WO2004052296A2 Dioxolane thymine and combinations for use against 3tc/ azt resistant strains of hiv |
| 06/24/2004 | WO2004052295A2 Compositions and methods for nutrition supplementation |
| 06/24/2004 | WO2004052294A2 Compositions and methods related to lipid:emodin formulations |